Compounds for the treatment of mitochondrial diseases
US10639287B2 · kind B2 · utility
0Cited by
1References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 1, 2015 |
| Grant date | May 5, 2020 |
| Priority date | — |
| Expiry date | May 10, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a compound of formula (Ia) for the use thereof in the treatment or prevention of diseases relating to the instability of mitochondrial DNA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.